We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Association of G9a Protein and Outcome of Patients With Endometrial Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01271764
First Posted: January 7, 2011
Last Update Posted: September 26, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Sheng-Mou Hsiao, Far Eastern Memorial Hospital
January 5, 2011
January 7, 2011
September 26, 2012
January 2011
July 2012   (Final data collection date for primary outcome measure)
The role of G9a protein in endometrial cancer [ Time Frame: overall survial, disease-free survival ]
We will correlate the G9a protein and outcome of endometrial cancer
Not Provided
Complete list of historical versions of study NCT01271764 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
Not Provided
Tumor invasion and metastasis are the major causes of cancer-related death. Some studies have found that histone methyltransferases, such as EZH2, specifically affect metastasis in breast, gastric and prostate cancer. The functional roles of other members of the HMT family such as G9a in cancer remain obscure. Therefore, the investigators will investigate whether G9a have a role in recurrence/metastasis of endometrial cancer.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Outcome of Endometrial Cancer
Other: no drug
The role of G9a protein in patients with endometrial cancer
No Intervention: endometrial cancer
Intervention: Other: no drug
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
97
September 2012
July 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • all cases with endometrial cancer underwent staging operation

Exclusion Criteria:

Sexes Eligible for Study: Female
20 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT01271764
099095-E
Not Provided
Not Provided
Not Provided
Sheng-Mou Hsiao, Far Eastern Memorial Hospital
Far Eastern Memorial Hospital
Not Provided
Not Provided
Far Eastern Memorial Hospital
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP